Key facts
- Alice Webb, 33, died after a non-surgical Brazilian butt lift procedure in September 2024, marking the first known fatality in the UK from such a treatment.
- The UK's aesthetics industry is largely unregulated, allowing individuals with minimal training to administer cosmetic injectables.
- Investigations have uncovered unsafe practices, including treatments in makeshift settings and the sale of unlabelled products.
- Patients have reported severe complications such as sepsis, infections, and disfigurement from cosmetic procedures.
- The number of cosmetic practitioners in the UK has surged, with a notable increase in non-medical aestheticians.
- While ministers are considering tighter regulations, concerns exist about balancing safety with economic impact and consumer choice.
The death of Alice Webb, a 33-year-old mother of five, following a non-surgical Brazilian butt lift (BBL) procedure in September 2024 has brought the safety of the UK's booming aesthetics industry into sharp focus. Webb is the first known person in the UK to die after undergoing this type of non-surgical cosmetic treatment, prompting an inquest and intensifying debate about the sector's lack of regulation.
Investigations by BBC News have revealed a landscape where cosmetic injectables are readily available in various settings, from beauty salons to rented office spaces. Practitioners have been found offering treatments with large volumes of filler from makeshift rooms, sometimes without proper consultations, and even selling prescription-only medicines and unlabelled weight-loss injections. Dozens of women have reported experiencing excruciating pain, infections, and hospitalizations resulting from procedures marketed as low-risk and pain-free.
Save Face, a cosmetic accreditation service, has documented numerous cases of serious harm, including severe disfigurement and perforated intestines. Director Ashton Collins described the situation as "horrific," highlighting that these procedures are occurring on high streets with minimal oversight.
The UK is noted as one of Europe's least-regulated markets for cosmetic injectables. Unlike many European countries where such treatments are reserved for medical professionals, in the UK, anyone can legally train to inject dermal fillers. This has contributed to the industry's rapid growth, with a study by Dr. Alexander Zargaran identifying nearly 20,000 practitioners in the UK in 2025, a substantial increase from just over 3,500 in 2023. The research also indicated a rise in non-medical aestheticians and a higher concentration of treatments in deprived areas, often with less access to qualified medical practitioners.
Ministers in Scotland and England have indicated intentions to tighten regulations. However, past consultations on licensing schemes have revealed concerns about proportionality, the potential impact on small businesses, and the risk of driving unregulated practices further underground. The current regulatory approach, described by JCCP chief executive Andrew Rankin as a 'lighter touch,' has historically balanced public safety with economic growth, but the consequences of this approach are now under intense scrutiny.